Heidelberg Pharma AG (ETR:HPHA)

BRIEF

published on 11/06/2025 at 07:14, 7 days 8 hours ago

Heidelberg Pharma's HDP-101 Advances in Multiple Myeloma Trial

Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma ATAC Technology
PRESS RELEASE

published on 11/06/2025 at 07:09, 7 days 8 hours ago

Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma
Heidelberg Pharma's lead ATAC candidate HDP-101 shows promising progress in Phase I/IIa trial for multiple myeloma, including stringent complete remissions. R&D webinar scheduled on 11 Nov 2025

Heidelberg Pharma HDP-101 Multiple Myeloma ATAC Candidate Phase I/IIa Trial
BRIEF

published on 11/03/2025 at 10:12, 10 days 5 hours ago

Heidelberg Pharma Reveals Promising Data for HDP-101 at ADC Congress 2025

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC Congress
PRESS RELEASE

published on 11/03/2025 at 10:07, 10 days 5 hours ago

Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar
Heidelberg Pharma to present new clinical data of lead ADC candidate HDP-101 at the World ADC Congress 2025 and host a webinar. Study results show promising anti-tumor activity in multiple myeloma patients

Webinar Clinical Data Heidelberg Pharma Multiple Myeloma ADC Candidate
BRIEF

published on 10/23/2025 at 08:02, 21 days 7 hours ago

Heidelberg Pharma's HDP-101 Receives Fast Track Designation from FDA

FDA Heidelberg Pharma HDP-101 Multiple Myeloma Fast Track Designation
PRESS RELEASE

published on 10/23/2025 at 07:57, 21 days 7 hours ago

Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
Heidelberg Pharma's lead ADC candidate HDP-101 granted Fast Track Designation by US FDA for the treatment of multiple myeloma. Accelerated review for innovative cancer therapy

Heidelberg Pharma Multiple Myeloma Fast Track Designation ADC Candidate US FDA
BRIEF

published on 10/09/2025 at 07:08, 1 month 4 days ago

Heidelberg Pharma's Nine-Month Update for 2025

Financial Results Clinical Trials Heidelberg Pharma HDP-101 Strategy Adjustment
PRESS RELEASE

published on 10/09/2025 at 07:03, 1 month 4 days ago

Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025
Heidelberg Pharma AG reports operational progress and financial figures for the first nine months of fiscal year 2025, focusing on lead ADC candidate HDP-101 and cost-saving measures

Financial Report Clinical Trial Cost-saving Measures Heidelberg Pharma AG ADC Candidate
BRIEF

published on 10/06/2025 at 16:03, 1 month 6 days ago

Heidelberg Pharma AG Revises Financial Guidance for 2025

Financial Guidance Heidelberg Pharma ADCs Operating Expenses Cash Requirements
PRESS RELEASE

published on 10/06/2025 at 15:58, 1 month 6 days ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its financial guidance for 2025, focusing on cost-saving measures. Sales, operating expenses, and cash requirements revised

Sales Financial Guidance Cost-saving Measures Heidelberg Pharma AG Operating Expenses

1 2 ... 9

Published on 11/13/2025 at 15:00, 23 minutes ago

Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting
Published on 11/13/2025 at 15:00, 23 minutes ago

Drilling Starts at Bitterroot Resources' Nighthawk Gold/Silver Project, Nevada
Published on 11/13/2025 at 14:45, 38 minutes ago

Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
Published on 11/13/2025 at 14:35, 48 minutes ago

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy
Published on 11/13/2025 at 14:30, 53 minutes ago

Gladstone Capital Corporation Earnings Call and Webcast Information

View all ACCESSWIRE

Published on 11/13/2025 at 15:05, 18 minutes ago

Reolink Early Black Friday Sale 2025 - Shop Early, Secure Sooner
Published on 11/13/2025 at 14:48, 35 minutes ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
Published on 11/13/2025 at 14:40, 43 minutes ago

Voltatron AG Advances Transformation and Accelerates Structural Recovery – Equity Turns Positive Following Balance Sheet Strengthening
Published on 11/13/2025 at 14:35, 48 minutes ago

Invictus Pharmacy First to Accept Crypto for Prescriptions
Published on 11/13/2025 at 14:30, 53 minutes ago

Delticom publishes Q3 business development: Revenues forecast for the full year 2025 raised

View all EQS

Published on 11/13/2025 at 08:45, 6 hours 38 minutes ago

World first: Air Liquide’s innovative technology
Published on 11/12/2025 at 17:58, 21 hours 25 minutes ago

PR_Peninsula Sells Its Stake in Carrefour
Published on 11/12/2025 at 17:53, 21 hours 29 minutes ago

PR_A New Core Shareholder Joins Carrefour’s Board of Directors
Published on 11/12/2025 at 17:45, 21 hours 38 minutes ago

October 2025
Published on 11/12/2025 at 15:30, 23 hours 53 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2025

View all LES ECHOS COMFI WIRE

News